Kaspofungin

Revisi sejak 25 Desember 2024 14.20 oleh Muhammad Anas Sidik (bicara | kontrib) (←Membuat halaman berisi '{{Infobox drug | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = | image = Caspofungin.svg | width = 275 | alt = <!-- Clinical data --> | pronounce = {{IPAc-en|ˌ|k|æ|s|p|oʊ|ˈ|f|ʌ|n|dʒ|ɪ|n}} {{respell|KAS|poh|FUN|jin}} | tradename = Cancidas | Drugs.com = {{drugs.com|monograph|caspofungin-acetate}} | MedlinePlus = a615001 | DailyMedID = Caspofungin | pregnancy_AU = B3 | pregnancy_AU_comment = | pregnancy_category = | routes_of_admin...')
(beda) ← Revisi sebelumnya | Revisi terkini (beda) | Revisi selanjutnya → (beda)

Kaspofungin (INN)[1][3] adalah obat antijamur lipopeptida dari Merck & Co., Inc..[4]

Kaspofungin
Nama sistematis (IUPAC)
(10R,12S)-N-{(2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11,15-trihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2',1'-l] [1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide
Data klinis
Nama dagang Cancidas
AHFS/Drugs.com monograph
MedlinePlus a615001
Data lisensi US Daily Med:pranala
Kat. kehamilan B3(AU)
Status hukum Harus dengan resep dokter (S4) (AU) -only (US) Preskripsi saja
Rute Intravenous
Data farmakokinetik
Bioavailabilitas 100% (intravenous use only)
Ikatan protein ~97%
Metabolisme Liver
Waktu paruh 9–11 hours
Ekskresi Kidney (41%), feces (35%)
Pengenal
Nomor CAS 162808-62-0 YaY
Kode ATC J02AX04
PubChem CID 16119814
DrugBank DB00520
ChemSpider 17277006
UNII F0XDI6ZL63
KEGG D07626 N
ChEBI CHEBI:474180 YaY
ChEMBL CHEMBL499808 YaY
Sinonim (4R,5S)-5-[(2-Aminoethyl)amino]-N2-(10,12-dimethyltetradecanoyl)-
4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6→1)-peptide
[1]:185

1-[(4R,5S)-5-[(2-Aminoethyl)amino]-N2-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine] pneumocandin B0[2]

Data kimia
Rumus C52H88N10O15 
  • InChI=1S/C52H88N10O15/c1-5-28(2)24-29(3)12-10-8-6-7-9-11-13-39(69)56-34-26-38(68)46(55-22-21-54)60-50(75)43-37(67)19-23-61(43)52(77)41(36(66)18-20-53)58-49(74)42(45(71)44(70)31-14-16-32(64)17-15-31)59-48(73)35-25-33(65)27-62(35)51(76)40(30(4)63)57-47(34)72/h14-17,28-30,33-38,40-46,55,63-68,70-71H,5-13,18-27,53-54H2,1-4H3,(H,56,69)(H,57,72)(H,58,74)(H,59,73)(H,60,75)/t28-,29+,30+,33+,34-,35-,36+,37-,38+,40-,41-,42-,43-,44-,45-,46-/m0/s1 YaY
    Key:JYIKNQVWKBUSNH-WVDDFWQHSA-N YaY

Caspofungin adalah penghambat pertama sintesis (1→3)-β-D-glukan jamur yang disetujui oleh Badan Pengawas Obat dan Makanan Amerika Serikat.[5] Caspofungin diberikan secara intravena.[2] Obat ini tercantum dalam Daftar Obat Esensial Organisasi Kesehatan Dunia.[6]

  1. ^ a b "International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary names (Rec.INN): List 42" (PDF). World Health Organization. 1999. Diakses tanggal 11 November 2016. 
  2. ^ a b Kesalahan pengutipan: Tag <ref> tidak sah; tidak ditemukan teks untuk ref bernama Cancidas FDA label
  3. ^ European Medicines Agency's list of authorised medicines for human use (C) Diarsipkan 17 October 2007 di Wayback Machine.
  4. ^ "Patent Covering Caspofungin". Diakses tanggal 18 March 2015. 
  5. ^ Deresinski SC, Stevens DA (June 2003). "Caspofungin". Clinical Infectious Diseases. 36 (11): 1445–57. doi:10.1086/375080alt=Dapat diakses gratis. PMID 12766841. 
  6. ^ World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090alt=Dapat diakses gratis. WHO/MHP/HPS/EML/2023.02.